CONMED Corp
Close on Oct 19, 2026
- Market cap
- $1.39B
- P/E (TTM)
- 24.9
- Dividend yield
- 1.30%
Earnings
Next report expected Nov 4, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 29, 2026 | During market hours | $343.50M | $0.77 | $1.38 |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 29, 2026 | During market hours | $317.00M | $0.45 | $0.89 |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 28, 2026 | During market hours | $373.20M | $0.54 | $1.43 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | During market hours | $337.90M | $0.09 | $1.08 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 30, 2025 | During market hours | $342.30M | $0.69 | $1.15 |
| Q1 FY2025 Ended Mar 31, 2025 | Apr 30, 2025 | During market hours | $321.30M | $0.19 | $0.95 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 5, 2025 | During market hours | $345.90M | $1.08 | $1.34 |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 30, 2024 | During market hours | $316.70M | $1.57 | $1.05 |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 31, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 24, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 31, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Jul 29, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Percentage Changenon-GAAP | Twelve Months Ending December 31, 2026 | -2.4% to 0.2% growth | New |
| Adjusted Diluted EPSnon-GAAP | Twelve Months Ending December 31, 2026 | $4.48 to $4.60 | Raised |
| Net Sales Growth, as reportedGAAP | Twelve Months Ending December 31, 2026 | -1.2% to -0.1% growth | New |
| Net Sales Growth, Constant Currencynon-GAAP | Twelve Months Ending December 31, 2026 | -1.7% to -0.7% growth | Lowered |
| Net Sales Growth, Organic Constant Currencynon-GAAP | Twelve Months Ending December 31, 2026 | 5% to 6% growth | Raised |
| Net Sales (GAAP)GAAP | Twelve Months Ending December 31, 2026 | $1.36B to $1.37B | Narrowed |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Conmed filed with the SEC
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY CONMED CORPORATION DATED JUNE 17, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Corporation Announces First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED DECEMBER 5, 2025, ISSUED BY CONMED CORPORATION
Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Corporation Announces Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JULY 7, 2025, ISSUED BY CONMED CORPORATION
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Largo, Florida, April 30, 2025 –
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Adds Mark Kaye
Executive or director change · Other events · EX-99.1 to Form 8-K
Quarter and Full-Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
J.P. Morgan 43rd Annual Healthcare Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Corporation Announces Third Quarter 2024 Financial Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
CONMED Corporation Announces Preliminary Third Quarter Financial Information
Results of operations · EX-99.1 to Form 8-K
Largo, Florida, July 31, 2024 –
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces First Quarter 2024
Results of operations · EX-99.1 to Form 8-K
Quarter and Full-Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces Third Quarter 2023
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces Second Quarter 2023
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces First Quarter 2023
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Announces Fourth Quarter and
Results of operations · EX-99.1 to Form 8-K
CONMED Corporation Withdraws 2022 Financial Outlook due to Temporary Impact from Software Implementation;
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Investor Presentation Curt R. Hartman
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Largo, Florida, October 26, 2022 –
Results of operations · EX-99.1 to Form 8-K
CONMED Completes Acquisition of Biorez, Inc.
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Announces Definitive Agreement to Acquire Biorez, Inc.
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Corporation Announces Second Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
June 13, 2022 – CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc.
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Corporation Announces Pricing of Upsized $700 Million Offering of Convertible Senior Notes
Other events · EX-99.1 to Form 8-K
CONMED Corporation Announces Private Offering of $600 Million of Convertible Senior Notes
Other events · EX-99.1 to Form 8-K
CONMED Corporation Announces First Quarter 2022 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CONMED Announces Definitive Agreement to Acquire In2Bones Global, Inc.
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Quarter and Full-Year 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K
Largo, Florida, October 27, 2021 –
Results of operations · EX-99.1 to Form 8-K